DYN — Dyne Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Dyne Therapeutics Inc

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases usin… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$18.15
Market Cap$2.87B
Float164.8M
Shares Outstanding165.3M
vs. Analyst Target+110.4% to analyst PT
Dividend RateNone
Analyst Target Price$38.19 (14 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$58.7M -$700,000 -$57.9M
2021 N/A -$149M -$1.1M -$149M
2022 N/A -$165M -$3.3M -$169M
2023 N/A -$236M -$2.5M -$233M
2024 N/A -$317M -$2.2M -$315M
2025 N/A -$446M -$2.0M -$438M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$111M
Sep 2025 N/A -$108M
Dec 2025 N/A -$112M
Mar 2026 N/A -$121M

Ownership & Float

Insider Ownership0.3%
Institutional Ownership115.4%
Short Float12.6%
% of All Funds Holding2.49%
Number of Funds Holding205

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$18.11Near-term / short-term trend
Weekly40-Week SMA$17.33Medium-term trend
Weekly80-Week SMA$15.86Cyclical trend (business cycle)
Weekly200-Week SMA$17.70Secular trend (multi-year)
Monthly10-Month SMA$17.75Near-term monthly trend
Monthly20-Month SMA$17.10Medium-term monthly trend
Monthly40-Month SMA$18.98Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$14.80 support 1.04x 1 months ago
$12.70 support 1.17x 6 months ago
$9.70 support 1.36x 8 months ago
$23.80 resistance 2.12x 15 months ago

Historical Earnings Reactions (24 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.73% -0.06% 45.83% 8.16% -2.39%
1 Day -0.40% -0.09% 50.00% 16.37% -12.89%
1 Week -3.28% -3.75% 41.67% 27.73% -36.46%
2 Weeks -3.05% -3.73% 47.83% 41.39% -29.59%
1 Month -2.07% -8.48% 39.13% 53.01% -46.24%

Next earnings: July 30, 2026 (63 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.12% 43.2% 266
Tuesday -0.13% 48.1% 295
Wednesday 0.60% 53.2% 293
Thursday -0.12% 45.3% 285
Friday 0.02% 46.3% 287

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 115.4%

Insider Transactions — Smart Summary

Total insider ownership: 0.3%

12-Month Insider Activity Summary

Total Filings31
Net Value+$369,112.363
Net Shares Change-2,783,083
% of Float-1.7%
C-Suite Filings18
Clusters Detected5

Key Insiders

NameTitleNet ValueFilingsActivity
Rhodes Jason P -$27.8M 3 N/A
Kersten Dirk -$20.0M 2 N/A
Cox John CEO and President +$911,000 1 1 buy
Posner Brian S +$160,840 4 4 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-06-06 – 2025-06-06 3 3 -$74,065.8 3 C-suite
2025-09-08 – 2025-09-09 3 3 -$108,038.677 3 C-suite
2025-12-05 – 2025-12-05 3 3 -$76,373.92 3 C-suite
2026-03-06 – 2026-03-13 7 5 -$15.7M 3 C-suite
2026-05-06 – 2026-05-14 5 5 -$2.1M 4 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-22 Posner Brian S +$42,800 Transaction at $17.12, now +6.0%
2026-04-01 Posner Brian S +$34,160 Transaction at $17.08, now +6.3%
2026-03-13 Posner Brian S +$38,700 Transaction at $19.35, now -6.2%
2026-03-10 Posner Brian S +$45,180 Transaction at $15.06, now +20.5%
2025-07-15 Cox John CEO and President +$911,000 Transaction at $9.11, now +99.2%
2026-03-11 Kersten Dirk -$13.1M Transaction at $19.09, now -4.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Dyne Therapeutics Inc (DYN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for DYN on Trend Edge →